As a result of the advances made in the field of molecular and population g
enetics, it is anticipated that several genes underlying ALS or predisposin
g to ALS might be identified in the near future. This will enable physician
s to establish a diagnosis of ALS based on molecular findings in addition t
o clinical and electrophysiological findings. At present, mutations in the
gene encoding for the free radical scavenging enzyme, superoxide dismutase
(SOD1), is the only basis for a molecular diagnosis. Other mutations are un
der investigation and confirmed results are eagerly awaited.